91 related articles for article (PubMed ID: 2666014)
1. In vitro activity of Ro 23-9424, ceftazidime, and eight other newer beta-lactams against 100 gram-positive blood culture isolates.
Jones RN; Barry AL
Diagn Microbiol Infect Dis; 1989; 12(2):143-7. PubMed ID: 2666014
[TBL] [Abstract][Full Text] [Related]
2. In vitro activities of a dual-action antibacterial agent, Ro 23-9424, and comparative agents.
Beskid G; Fallat V; Lipschitz ER; McGarry DH; Cleeland R; Chan K; Keith DD; Unowsky J
Antimicrob Agents Chemother; 1989 Jul; 33(7):1072-7. PubMed ID: 2782857
[TBL] [Abstract][Full Text] [Related]
3. Antimicrobial activity of a new antipseudomonal dual-action drug, Ro 25-0534.
Jones RN; Sanchez ML
Diagn Microbiol Infect Dis; 1994 Jan; 18(1):61-8. PubMed ID: 8026159
[TBL] [Abstract][Full Text] [Related]
4. Antimicrobial activity of Ro 23-9424, a novel ester-linked codrug of fleroxacin and desacetylcefotaxime.
Jones RN; Barry AL; Thornsberry C
Antimicrob Agents Chemother; 1989 Jun; 33(6):944-50. PubMed ID: 2504106
[TBL] [Abstract][Full Text] [Related]
5. In vitro activity of Ro 23-9424, a dual-action cephalosporin, compared with activities of other antibiotics.
Gu JW; Neu HC
Antimicrob Agents Chemother; 1990 Feb; 34(2):189-95. PubMed ID: 2327765
[TBL] [Abstract][Full Text] [Related]
6. Comparative in-vitro activities of trovafloxacin, ciproflaxacin, ofloxacin, and broad-spectrum beta-lactams against aerobe blood culture isolates.
Seifert H
Zentralbl Bakteriol; 1998 Dec; 288(4):509-18. PubMed ID: 9987189
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity of Ro 23-9424, a dual-acting cephalosporin-quinolone antimicrobial agent.
Qadri SM; Ueno Y; Saldin H; Cunha BA
J Clin Pharmacol; 1993 Oct; 33(10):923-8. PubMed ID: 8227462
[TBL] [Abstract][Full Text] [Related]
8. Mode of action of the dual-action cephalosporin Ro 23-9424.
Georgopapadakou NH; Bertasso A; Chan KK; Chapman JS; Cleeland R; Cummings LM; Dix BA; Keith DD
Antimicrob Agents Chemother; 1989 Jul; 33(7):1067-71. PubMed ID: 2675755
[TBL] [Abstract][Full Text] [Related]
9. In vitro activity of Ro 23-9424, a dual-action antibacterial agent, against bacterial isolates from cancer patients compared with those of other agents.
Rolston KV; Nguyen HT; Ho DH; LeBlanc B; Bodey GP
Antimicrob Agents Chemother; 1992 Apr; 36(4):879-82. PubMed ID: 1503453
[TBL] [Abstract][Full Text] [Related]
10. Anti-Brucella activity of Ro 23-9424, a dual-action antibacterial.
Qadri SM; Ueno Y; Ayub A
Chemotherapy; 1993; 39(6):386-9. PubMed ID: 8222864
[TBL] [Abstract][Full Text] [Related]
11. Escherichia coli resistant to cephalosporins and quinolones is still susceptible to the cephalosporin-quinolone ester Ro 23-9424.
Pace J; Bertasso A; Georgopapadakou NH
Antimicrob Agents Chemother; 1991 May; 35(5):910-5. PubMed ID: 1649574
[TBL] [Abstract][Full Text] [Related]
12. In vivo evaluation of a dual-action antibacterial, Ro 23-9424, compared to cefotaxime and fleroxacin.
Beskid G; Siebelist J; McGarry CM; Cleeland R; Chan K; Keith DD
Chemotherapy; 1990; 36(2):109-16. PubMed ID: 2107064
[TBL] [Abstract][Full Text] [Related]
13. A multicentre study of the in-vitro activity of cefotaxime, cefuroxime, ceftazidime, ofloxacin and ciprofloxacin against blood and urinary pathogens.
Amyes SG; Baird DR; Crook DW; Gillespie SH; Howard AJ; Oppenhiem BA; Pedler SJ; Paull A; Tompkins DS; Lawrie SA
J Antimicrob Chemother; 1994 Nov; 34(5):639-48. PubMed ID: 7706159
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of fleroxacin (Ro23-6240), a new fluorinated 4-quinolone against isolates from cancer patients.
Rolston K; Ho DH; LeBlanc B; Bodey GP
Chemotherapy; 1988; 34(6):448-54. PubMed ID: 3149568
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial activity of Ro 24-6778, a covalent bonding of desmethylfleroxacin and desacetylcefotaxime.
Jones RN
Diagn Microbiol Infect Dis; 1990; 13(3):253-9. PubMed ID: 2116952
[TBL] [Abstract][Full Text] [Related]
16. [Dual cephalosporins--a return of fixed combinations of antibiotics?].
Krcméry V
Cas Lek Cesk; 1990 Jul; 129(29):914-6. PubMed ID: 2393897
[TBL] [Abstract][Full Text] [Related]
17. RO 23-9424, a new cephalosporin 3'-quinolone: in-vitro antimicrobial activity and tentative disc diffusion interpretive criteria.
Pfaller MA; Barry AL; Fuchs PC
J Antimicrob Chemother; 1993 Jan; 31(1):81-8. PubMed ID: 8444677
[TBL] [Abstract][Full Text] [Related]
18. In vitro activity of ceftazidime, cefotaxime and gentamicin against 11,521 clinical isolates of bacteria.
Steinbakk M; Midtvedt T; Lingaas E; Gardsjord G
Acta Pathol Microbiol Immunol Scand B; 1987 Dec; 95(6):337-46. PubMed ID: 3326398
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity of Ro 23-9424 against clinical isolates of Legionella species.
Edelstein PH; Edelstein MA
Antimicrob Agents Chemother; 1992 Nov; 36(11):2559-61. PubMed ID: 1489206
[TBL] [Abstract][Full Text] [Related]
20. The comparative activity of fleroxacin, three other quinolones and eight unrelated antimicrobial agents.
McCarter YS; Mazens-Sullivan MF; Bartlett RC
Chemotherapy; 1992; 38(5):308-18. PubMed ID: 1337507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
